New study adds to weight loss drug makers Novo Nordisk and Eli Lilly investment case

--:--

Flagship Asset Management fund manager, Philip Short
New study adds to weight loss drug makers Novo Nordisk and Eli Lilly investment case

24 Jun 12PM English South Africa Business

Leo Dlamini, Principal Officer Bestmed Health and Wellness – Medical costs out of control

24 Oct 12PM 13 min

Jeremy Sampson, MD of Brand Finance Africa The Brandfather

24 Oct 12PM 15 min

Warwick Lucas, Private Clients Portfolio Manager at Vunani, and Raymond Parsons from the NWU Business School The Week that Was

24 Oct 12PM 11 min

Chantal Marx - Head of Investment Research and Content View from the market

24 Oct 12PM 9 min

Andries van Heerden, CEO Afrimat takes a tumble

24 Oct 11AM 7 min

All episodes